|
Evidence of a net release of tissue-type plasminogen activator across the human cerebral vasculature.
Thromb Haemost. 2004 May; 91(5):1019-25.
Jern C, Blomstrand C, Westerlind A |
|
Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina.
Thromb Haemost. 2004 May; 91(5):1026-30.
Maruyoshi H, Kojima S, Funahashi T, Miyamoto S, Hokamaki J, Soejima H, Sakamoto T, Kawano H, Yoshimura M, Kitagawa A, Matsuzawa Y, Ogawa H. |
|
Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk.
Thromb Haemost. 2004 May; 91(5):861-72.
Hoekstra T, Geleijnse JM, Schouten EG, Kluft C. |
|
Tissue Plasminogen Activator -7351C/T Enhancer Polymorphism Is a Risk Factor for Lacunar Stroke.
Stroke. 2004 May; 35(5):1090-4. Epub 2004 Mar 18
Jannes J, Hamilton-Bruce MA, Pilotto L, Smith BJ, Mullighan CG, Bardy PG, Koblar SA. |
|
Integrin alpha {sub}Mbeta {sub}2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils.
J Biol Chem. 2004 Abr; 279(17):18063-72. Epub 2004 Feb 9
Pluskota E, Soloviev DA, Bdeir K, Cines DB, Plow EF. |
|
Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of {gamma} Ala327Thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism.
Blood. 2004 Abr; 103(8):3045-3050. Epub 2004 Ene 8
Hamano A, Mimuro J, Aoshima M, Itoh T, Kitamura N, Nishinarita S, Takano K, Ishiwata A, Kashiwakura Y, Niwa K, Ono T, Madoiwa S, Sugo T, Matsuda M, Sakata Y. |
|
A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
J Biol Chem. 2004 Abr; 279(14):13333-9. Epub 2004 Ene 8
Schneider MM, Nesheim ME. |
|
Activated thrombin-activable fibrinolysis Inhibitor reduces the ability of high molecular weight fibrin degradation products to protect Plasmin from antiplasmin.
J Biol Chem. 2004 Abr; 279(14):13340-5. Epub 2004 Ene 8
Schneider MM, Brufatto N, Neill EK, Nesheim ME. |
|
A rapid microtitre plate screening method for in vitro assessment of fibrinolysis: a preliminary report.
Blood Coagul Fibrinolysis. 2004 Abr; 15(3):273-8.
Paul-Brent PA, Cattley TN, Myers SP, Brooks L, Cheras PA. |
|
The effect of submaximal exercise on fibrinolysis.
Blood Coagul Fibrinolysis.. 2004 Abr; 15(3):227-34.
Fras Z, Keber D, Chandler WL |
|
Relationship between the door-to-TIMI-3 flow time and the infarct size in patients suffering from acute myocardial infarction: analysis based on the fibrinolysis and subsequent transluminal (FAST-3) trial.
Circ J. . 2004 Abr; 68(4):280-5.
Watanabe K, Nagao K, Watanabe I, Kanmatsuse K |
|
Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.
J Intern Med. 2004 Abr; 255(4):448-56.
Mavri A, Alessi MC, Juhan-Vague I. |
|
The effects of perioperatively administered crystalloids and colloids on concentrations of molecular markers of activated coagulation and fibrinolysis.
Blood Coagul Fibrinolysis. 2004 Abr; 15(3):213-9.
Fries D, Streif W, Margreiter J, Klingler A, Kuhbacher G, Schobersberger W, Wirleitner B, Innerhofer |
|
Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.
Blood. 2004 Mar; 103(6):2157-61. Epub 2003 Nov 20
Colucci M, Binetti BM, Tripodi A, Chantarangkul V, Semeraro N. |
|
The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors.
Thromb Haemost. 2004 Mar; 91(3):425-37.
Gils A, Declerck PJ |
|
Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays.
Br J Haematol. 2004 Mar; 124(5):659-65.
Guimaraes AH, Van Tilburg NH, Vos HL, Bertina RM, Rijken DC |
|
Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Thromb Haemost. 2004 Mar; 91(3):473-9.
Guimaraes AH, Rijken DC |
|
Effects of C-reactive protein on atherogenic mediators and adrenomedullin in human coronary artery endothelial and smooth muscle cells.
Biochem Biophys Res Commun. 2004 Feb; 314(4):1057-63.
Nagoshi Y, Kuwasako K, Cao YN, Kitamura K, Eto T |
|
Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitor
J Biol Chem. 2004 Feb; 279(8):6620-8. Epub 2003 Dic 4
Marx PF, Havik SR, Marquart JA, Bouma BN, Meijers JC. |
|
The in vitro and in vivo effect of tPA and PAI-1 on blood vessel tone.
Blood. 2004 Feb; 103(3):897-902. Epub 2003 Sep 25
Nassar T, Akkawi S, Shina A, Haj-Yehia A, Bdeir K, Tarshis M, Heyman SN, Higazi AA. |
